PFM Health Sciences’s Allena Pharmaceuticals ALNA Stock Holding History

PFM Health Sciences’s Portfolio ALNA Stock Details ALNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-284,285	Closed	-$168K	–	81
2021 Q4	$168K	Hold	284,285	–	–	0.01%	71
2021 Q3	$256K	Hold	284,285	–	–	0.01%	85
2021 Q2	$370K	Hold	284,285	–	–	0.01%	84
2021 Q1	$395K	Hold	284,285	–	–	0.01%	86
2020 Q4	$364K	Hold	284,285	–	–	0.01%	85
2020 Q3	$421K	Hold	284,285	–	–	0.02%	75
2020 Q2	$449K	Hold	284,285	–	–	0.02%	76
2020 Q1	$274K	Buy	+284,285	New	+$569K	0.02%	61
2019 Q4	–	Sell	-486,978	Closed	-$1.92M	–	87
2019 Q3	$1.92M	Sell	486,978 -301,980	-38%	-$1.3M	0.06%	68
2019 Q2	$3.21M	Sell	788,958 -674,250	-46%	-$3.68M	0.06%	81
2019 Q1	$10.3M	Sell	1,463,208 -304,896	-17%	-$2.21M	0.23%	79
2018 Q4	$9.64M	Sell	1,768,104 -464	-0%	-$4K	0.26%	72
2018 Q3	$19M	Buy	1,768,568 +28,763	+2%	+$316K	0.28%	93
2018 Q2	$22.7M	Buy	1,739,805 +275,911	+19%	+$3.98M	0.36%	85
2018 Q1	$15.2M	Sell	1,463,894 -310	-0%	-$2.59K	0.31%	79
2017 Q4	$13.3M	Buy	+1,464,204	New	+$18M	0.31%	70

Other funds holding ALNA

TGI

TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PFM Health Sciences's ALNA Position: Q1 2022 in Review

PFM Health Sciences sold out of Allena Pharmaceuticals (ALNA) in Q1 2022, closing a stake of 284,285 shares — an estimated $168K sold.

PFM Health Sciences first reported a position in ALNA in Q4 2017 and held it in 16 quarters. The position peaked at $22.7M in Q2 2018. 28 funds tracked by Wall St. Rank hold ALNA as of Q1 2022.

PFM Health Sciences reported no remaining Allena Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
PFM Health Sciences sold 284,285 Allena Pharmaceuticals shares in Q1 2022, an estimated $168K.
PFM Health Sciences first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 16 quarters.
PFM Health Sciences's Allena Pharmaceuticals position peaked at $22.7M in Q2 2018.
28 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q1 2022.

Based on PFM Health Sciences's 13F filing for Q1 2022, filed 16 May 2022.